Fast Facts

ZIMBABWE continues to record positive strides in the fight against the deadly Tuberculosis disease with the estimated incidence rate going down from 242 per 100 000 in 2015 to 204 per 100 000 in 2022. While the country has made progress, TB remains a leading cause of death and there are still many challenges.

Challenges

Missed cases: Many people with TB go undiagnosed and untreated.

Drug-resistant TB: There is a significant burden of drug-resistant TB.

High out-of-pocket costs: Many TB patients face high costs for treatment.

Limited diagnostic capacity: There are few facilities that can conduct TB sputum culture microscopy.

Stigma and discrimination: People with TB may face stigma and discrimination.

Poverty: Poverty can make it difficult for people to access health services.

Progress

Zimbabwe has made progress in reducing the TB burden.

It launched the Multi-Sectoral Accountability Framework for TB (MAF-TB) to increase efforts to end TB.

Zimbabwe has free TB diagnosis at national laboratories.

Treatment

In 2020, the TB treatment success rate in Zimbabwe was 88%.

TB is the second leading cause of death in Zimbabwe.

To ensure that TB services are brought close to where people live, the Ministry of Health and Child Care has been implementing targeted screening for active TB (TaS4TB) to detect missed TB cases amongst high-risk and hard-to-reach populations in Zimbabwe since 2014.

Related Posts

Former Mr Cruiser director admits using company deal for personal anniversary getaway

Court Correspondent The trial of Michael Gordon Smith, a former director of MA Auto Suppliers (trading as Mr Cruiser), intensified this week as he faced rigorous cross-examination over a series…

Zim committed to modernising data collection

Ruth Butaumocho in NAIROBI, Kenya ZIMBABWE remains committed to modernise official statistics and promote evidence-based decision-making through innovative data dissemination platforms such as open data platforms and supportive national institutions,…

Leave a Reply

Your email address will not be published. Required fields are marked *

×
×